Vitality Watch

Dossier pubmed review 07-aug-2026
Narrative review or expert overview without new data

Acute lung injury in the context of aging: Pathogenetic mechanisms and therapeutic strategies.

Key claim: Aging increases ALI/ARDS susceptibility, progression, and worse prognosis via immune dysregulation, chronic inflammation, cellular senescence, mitochondrial dysfunction, and impaired lung repair, and therapies targeting these aging-related alterations may enable more precise care for elderly patients.

Abstract

Acute lung injury (ALI) and its severe form, acute respiratory distress syndrome (ARDS), remain major challenges in critical care medicine, characterized by alveolar-capillary barrier disruption, excessive inflammation, and impaired gas exchange. With the growing aging population, aging has emerged as an important determinant of ALI/ARDS susceptibility, progression, and prognosis. Aging promotes pulmonary vulnerability through multiple interconnected mechanisms, including immune dysregulation, chronic inflammation, cellular senescence, mitochondrial dysfunction, and impaired tissue repair capacity, thereby facilitating inflammatory imbalance and defective lung regeneration. This review summarizes the key mechanisms underlying aging-associated susceptibility to ALI and discusses emerging therapeutic strategies targeting aging-related alterations, with emphasis on their translational challenges and clinical implications. These insights may provide new perspectives for the development of precision prevention and treatment approaches for elderly patients with ALI/ARDS.

Why this matters

Aging increases ALI/ARDS susceptibility, progression, and worse prognosis via immune dysregulation, chronic inflammation, cellular senescence, mitochondrial dysfunction, and impaired lung repair, and therapies targeting these aging-related alterations may enable more precise care for elderly patients.

Source

Link

Briefing card

Acute lung injury in the context of aging: Pathogenetic mechanisms and therapeutic strategies.
Stage: review · pubmed · 07-aug-2026

Aging increases ALI/ARDS susceptibility, progression, and worse prognosis via immune dysregulation, chronic inflammation, cellular senescence, mitochondrial dysfunction, and impaired lung repair, and therapies targeting these aging-related alterations may enable more precise care for elderly patients.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.arr.2026.103289

build build 880 · 2bcef25 · 2026-11-18